LIMK1 expression was significantly correlated with shorter survival of AML patients along with FLT3 mutations, lysine methyltransferase 2A (KMT2A) rearrangements and elevated homeobox D10 (HOXD10) gene expression [101]. This evidence concerns the gene HOXD10 and acute myeloid leukemia.